PRESS RELEASE – BW – Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpu…
Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary DysplasiaFavorable safety profile confirmed also in fourth and final cohort including babies born at earliest …